KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Return on Invested Capital (2016 - 2026)

West Pharmaceutical Services has reported Return on Invested Capital over the past 17 years, most recently at 0.16% for Q1 2026.

  • Quarterly Return on Invested Capital changed 0.0% to 0.16% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.16% through Mar 2026, changed 0.0% year-over-year, with the annual reading at 0.15% for FY2025, 1.0% down from the prior year.
  • Return on Invested Capital was 0.16% for Q1 2026 at West Pharmaceutical Services, up from 0.14% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 0.26% in Q1 2022 and troughed at 0.14% in Q4 2025.
  • The 5-year median for Return on Invested Capital is 0.18% (2023), against an average of 0.18%.
  • Biggest five-year swings in Return on Invested Capital: grew 6bps in 2022 and later decreased -7bps in 2023.
  • Tracing WST's Return on Invested Capital over 5 years: stood at 0.22% in 2022, then decreased by -17bps to 0.18% in 2023, then dropped by -12bps to 0.16% in 2024, then decreased by -12bps to 0.14% in 2025, then grew by 12bps to 0.16% in 2026.
  • According to Business Quant data, Return on Invested Capital over the past three periods came in at 0.16%, 0.14%, and 0.15% for Q1 2026, Q4 2025, and Q3 2025 respectively.